Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
18.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.42
|
3.50
|
3.63
|
3.22
|
3.91
|
3.43
|
|
|
1 371 989.03
|
3 534.00
|
3.57
|
3.62
|
3.50
|
3.42
|
3.92
|
3.63
|
|
|
1 716 902.57
|
3 178.00
|
3.00
|
3.65
|
3.42
|
3.2601
|
3.64
|
3.50
|
|
|
3 178 535.46
|
1 515.00
|
3.00
|
3.50
|
3.25
|
3.1967
|
3.43
|
3.37
|
|
|
153 419.35
|
1 198.00
|
3.10
|
3.50
|
3.38
|
3.14
|
3.47
|
3.27
|
|
|
281 399.53
|
1 003.00
|
3.30
|
3.53
|
3.37
|
3.29
|
3.53
|
3.38
|
|
|
221 675.87
|
1 295.00
|
3.15
|
3.92
|
3.38
|
3.32
|
3.59
|
3.38
|
|
|
361 476.37
|
1 226.00
|
3.25
|
3.92
|
3.47
|
3.26
|
3.75
|
3.42
|
|
|
615 706.25
|
1 343.00
|
3.30
|
3.92
|
3.42
|
3.35
|
3.5683
|
3.46
|
|
|
357 658.21
|
1 506.00
|
3.01
|
3.75
|
3.70
|
3.36
|
3.7457
|
3.38
|
|
|
351 954.85
|
1 294.00
|
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.